Literature DB >> 23371846

Diffusion-weighted imaging of the prostate: Comparison of b1000 and b2000 image sets for index lesion detection.

Andrew B Rosenkrantz1, Nicole Hindman, Ruth P Lim, Kasturi Das, James S Babb, Thais C Mussi, Samir S Taneja.   

Abstract

PURPOSE: To compare tumor detection on acquired diffusion-weighted (DW) images and apparent diffusion coefficient (ADC) maps, obtained using b-values of 1000 s/mm(2) and 2000 s/mm(2) , using radical prostatectomy as the reference.
MATERIALS AND METHODS: In all, 29 prostate cancer patients who underwent 3T magnetic resonance imaging (MRI) including DW imaging using b-values of 1000 s/mm(2) and 2000 s/mm(2) were included. Two radiologists independently evaluated four image sets during different sessions and recorded the location and diameter of the dominant lesion: DW images acquired using b-values of 1000 s/mm(2) and 2000 s/mm(2) and ADC maps calculated using maximal b-values of 1000 s/mm(2) and 2000 s/mm(2) . Findings were correlated with the location and diameter of the dominant lesion at prostatectomy. Tumor-to-PZ contrast was also calculated, unblinded to pathology.
RESULTS: Both readers achieved significantly higher sensitivity for DW images obtained using a b-value of 2000 s/mm(2) than 1000 s/mm(2) (P < 0.001), although there was no difference in sensitivity between ADC maps calculated using the two b-values (P ≥ 0.309). Tumor-to-PZ contrast was higher for DW images using a b-value of 2000 s/mm(2) (P = 0.067), although it was not different between the two corresponding ADC maps (P = 0.544). For both readers, correlations with tumor diameters were higher for either ADC map (r = 0.59-0.73) than for either acquired DW image set (r = 0.03-0.57).
CONCLUSION: Use of a b-value of 2000 s/mm(2) compared with a b-value of 1000 s/mm(2) resulted in improved tumor sensitivity and higher tumor-to-PZ contrast on the acquired DW images, although performance of the ADC maps corresponding with the two b-values was similar. Correlation with tumor size was greater for either ADC map than for either acquired DW image set.
Copyright © 2013 Wiley Periodicals, Inc., a Wiley company.

Entities:  

Keywords:  MRI; diffusion-weighted imaging; prostate cancer; prostatectomy

Mesh:

Year:  2013        PMID: 23371846     DOI: 10.1002/jmri.24016

Source DB:  PubMed          Journal:  J Magn Reson Imaging        ISSN: 1053-1807            Impact factor:   4.813


  29 in total

1.  MRI for prostate cancer: can computed high b-value DWI replace native acquisitions?

Authors:  Salma Jendoubi; Mathilde Wagner; Sarah Montagne; Malek Ezziane; Julien Mespoulet; Eva Comperat; Candice Estellat; Amandine Baptiste; Raphaele Renard-Penna
Journal:  Eur Radiol       Date:  2019-03-18       Impact factor: 5.315

2.  PI-RADS version 2: evaluation of diffusion-weighted imaging interpretation between b = 1000 and b = 1500 s mm-2.

Authors:  Mi-Ri Kwon; Chan Kyo Kim; Jae-Hun Kim
Journal:  Br J Radiol       Date:  2017-10-06       Impact factor: 3.039

3.  Differentiating papillary type I RCC from clear cell RCC and oncocytoma: application of whole-lesion volumetric ADC measurement.

Authors:  Anna K Paschall; S Mojdeh Mirmomen; Rolf Symons; Amir Pourmorteza; Rabindra Gautam; Amil Sahai; Andrew J Dwyer; Maria J Merino; Adam R Metwalli; W Marston Linehan; Ashkan A Malayeri
Journal:  Abdom Radiol (NY)       Date:  2018-09

4.  Synthesizing High-b-Value Diffusion-weighted Imaging of the Prostate Using Generative Adversarial Networks.

Authors:  Lei Hu; Da-Wei Zhou; Yun-Fei Zha; Liang Li; Huan He; Wen-Hao Xu; Li Qian; Yi-Kun Zhang; Cai-Xia Fu; Hui Hu; Jun-Gong Zhao
Journal:  Radiol Artif Intell       Date:  2021-06-02

5.  Diffusion-weighted MR imaging of the pancreas: optimizing b-value for visualization of pancreatic adenocarcinoma.

Authors:  Yoshihiko Fukukura; Toshikazu Shindo; Hiroto Hakamada; Koji Takumi; Tomokazu Umanodan; Masanori Nakajo; Kiyoshisa Kamimura; Aya Umanodan; Junnichi Ideue; Takashi Yoshiura
Journal:  Eur Radiol       Date:  2016-01-06       Impact factor: 5.315

Review 6.  Image-guided focal therapy for prostate cancer.

Authors:  Sandeep Sankineni; Bradford J Wood; Soroush Rais-Bahrami; Annerleim Walton Diaz; Anthony N Hoang; Peter A Pinto; Peter L Choyke; Barış Türkbey
Journal:  Diagn Interv Radiol       Date:  2014-11       Impact factor: 2.630

7.  Comparison of calculated and acquired high b value diffusion-weighted imaging in prostate cancer.

Authors:  Kinzya B Grant; Harsh K Agarwal; Joanna H Shih; Marcelino Bernardo; Yuxi Pang; Dagane Daar; Maria J Merino; Bradford J Wood; Peter A Pinto; Peter L Choyke; Baris Turkbey
Journal:  Abdom Imaging       Date:  2015-03

8.  The Primacy of High B-Value 3T-DWI Radiomics in the Prediction of Clinically Significant Prostate Cancer.

Authors:  Alessandro Bevilacqua; Margherita Mottola; Fabio Ferroni; Alice Rossi; Giampaolo Gavelli; Domenico Barone
Journal:  Diagnostics (Basel)       Date:  2021-04-21

9.  Defining the index lesion for potential salvage partial or hemi-gland ablation after radiation therapy for localized prostate cancer.

Authors:  Gregory T Chesnut; Amy L Tin; Arjun Sivaraman; Toshikazu Takeda; Taehyoung Lee; Jonathan Fainberg; Nicole Benfante; Daniel D Sjoberg; Hebert Alberto Vargas; Samson W Fine; Peter T Scardino; James A Eastham; Jonathan A Coleman; Karim A Touijer; Michael J Zelefsky; Behfar Ehdaie
Journal:  Urol Oncol       Date:  2021-02-12       Impact factor: 2.954

10.  Low-to-high b value DWI ratio approaches in multiparametric MRI of the prostate: feasibility, optimal combination of b values, and comparison with ADC maps for the visual presentation of prostate cancer.

Authors:  Yin Xi; Alexander Liu; Franklin Olumba; Parker Lawson; Daniel N Costa; Qing Yuan; Gaurav Khatri; Takeshi Yokoo; Ivan Pedrosa; Robert E Lenkinski
Journal:  Quant Imaging Med Surg       Date:  2018-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.